Day One

• Disentangling biological signal from environmental and management variability in on-farm trials
• Applying statistical and experimental controls tailored specifically to living products
• Building confidence in outcomes through replication strategies and cross-site validation

• Designing field trials that answer grower and buyer questions tied to risk, return on investment, and repeat purchase decisions
• Demonstrating consistency and reliability at scale and forming conditions that reflect real commercial farming operations
• Translating field data into credible value stories that support sales, claims, and longterm market adoption

Join our speed networking session tailored for agbiotech professionals, distributors, investors, growers, service providers and more, to connect with fellow industry peers and facilitate rapid, yet meaningful exchanges of insights and expertise. Elevate your conference experience during this session designed to form impactful connections within the space.

• Designing the product concept with efficacy, downstream scale-up, application method, and regulatory requirements in mind
• Decoupling strain selection from biocontrol activity to enable more stable and competitive microbial products

• Characterizing microbial and biochemical mechanisms of action using molecular, biochemical, and physiological assays to link function with agronomic outcomes
• Validating mechanisms of action through controlled experimental systems that distinguish biological activity from environmental and background effects
• Translating mechanistic insight into improved product design, formulation strategy, and performance consistency under variable use conditions

• Developing biostimulant products that deliver consistent, measurable performance under variable field and environmental conditions
• Improving performance consistency through better formulation, validation, and field relevant testing to build grower confidence and support healthier yields
• Aligning scientific evidence, product positioning, and expectation management to drive correct use and sustained biostimulant adoption

• Examining common drivers of cell viability loss across storage, handling, and field deployment
• Sharing applied formulation approaches — including carrier systems, protective chemistries, and delivery formats — used to improve shelf life and field efficacy
• Discussing how formulation and development workflows can better translate lab performance into scalable manufacturing and reliable on-farm performance

• Exploring fermentation and formulation approaches for peptides, metabolites, and other emerging biological technologies
• Developing synergistic products combining microbes with nutrients, stimulants, or novel biological actives
• Innovating out-of-the-box production and formulation models, including miniaturized manufacturing, energy-efficient systems, and circular-economy approaches 

• Optimizing large scale production and fermentation formats (e.g. Volaris™) for microalgae as a non-traditional and undomesticated microbial cultivar for industrial agriculture use
• Developing a pipeline of new and improved formulations to satisfy farmers’ needs to create a suite of products for the full crop lifecycle from “seed-to-stubble”
• Harnessing the power of microalgae as a unique microbial chassis to innovate and address challenges of modern-day agriculture

Contribute to the conversation and share your cutting-edge research with the agbiological community. Register your place to submit an abstract for review and showcase your work. Please visit the website for the T&Cs of presenting a poster

•  Clarifying how regulator roles and interagency coordination (USDA and/or EPA) shapes pathways to market for microbial and biostimulant products
• Outlining regulatory expectations genetically modified microbes, data gaps, and scientific priorities needed to support risk-based, science-driven oversight
• Updating stakeholders on biostimulant harmonization efforts, state-level considerations, and opportunities for early engagement with regulators

• Discuss how harmonized global data packages provide the opportunity to streamline regulatory submissions and reduce duplication of costly regional studies
• Identify that the first critical step to aligning across jurisdictions is to develop standardized datasets based on a comprehensive overview of fermentation processes, QM/QA/QC parameters, and product specifications
• Participate in proactive dialogue with regulatory authorities to fully describe product composition, innovations in product fermentation and formulation to develop crossborder datasets that support scalable regulatory and commercialization strategies for new territories